Verition Fund Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.3M | Buy |
228,415
+114,347
| +100% | +$3.15M | 0.03% | 713 |
|
|
2025
Q1 | $3.23M | Buy |
114,068
+4,649
| +4% | +$132K | 0.02% | 977 |
|
|
2024
Q4 | $4.55M | Buy |
109,419
+70,803
| +183% | +$2.94M | 0.02% | 757 |
|
|
2024
Q3 | $2.58M | Buy |
38,616
+19,538
| +102% | +$1.31M | 0.01% | 898 |
|
|
2024
Q2 | $2.27M | Sell |
19,078
-8,921
| -32% | -$1.06M | 0.01% | 824 |
|
|
2024
Q1 | $2.98M | Buy |
27,999
+11,057
| +65% | +$1.18M | 0.02% | 711 |
|
|
2023
Q4 | $1.68M | Buy |
+16,942
| New | +$1.68M | 0.01% | 733 |
|
|
2023
Q2 | – | Sell |
-9,400
| Closed | -$1.44M | – | 2125 |
|
|
2023
Q1 | $1.44M | Sell |
9,400
-130
| -1% | -$20K | 0.02% | 733 |
|
|
2022
Q4 | $1.71M | Sell |
9,530
-3,582
| -27% | -$643K | 0.03% | 569 |
|
|
2022
Q3 | $1.55M | Buy |
13,112
+9,676
| +282% | +$1.14M | 0.02% | 900 |
|
|
2022
Q2 | $490K | Sell |
3,436
-4,908
| -59% | -$700K | 0.01% | 1408 |
|
|
2022
Q1 | $1.44M | Buy |
8,344
+3,863
| +86% | +$665K | 0.02% | 804 |
|
|
2021
Q4 | $1.14M | Buy |
4,481
+2,753
| +159% | +$699K | 0.01% | 834 |
|
|
2021
Q3 | $665K | Buy |
1,728
+793
| +85% | +$305K | 0.01% | 866 |
|
|
2021
Q2 | $220K | Sell |
935
-3,024
| -76% | -$712K | ﹤0.01% | 1396 |
|
|
2021
Q1 | $518K | Sell |
3,959
-8,703
| -69% | -$1.14M | 0.01% | 749 |
|
|
2020
Q4 | $1.32M | Buy |
+12,662
| New | +$1.32M | 0.01% | 365 |
|
|
2020
Q3 | – | Sell |
-20,715
| Closed | -$1.33M | – | 1168 |
|
|
2020
Q2 | $1.33M | Buy |
+20,715
| New | +$1.33M | 0.04% | 267 |
|